Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-041467

Options or other derivatives

  • General Counsel and Secretary acquired 64,166 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2025-03-14 Grant or award · Stock Option (Right to Buy) +36,666 36,666 D
KASINGER JAMES R. General Counsel and Secretary 2025-03-14 Grant or award · Restricted Stock Units +27,500 27,500 D
Loading xslF345X05/ownership.xml…